An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder
NCT00057226
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
365
Enrollment
INDUSTRY
Sponsor class
Conditions
Depressive Disorder, Major
Interventions
DRUG:
Radafaxine
Sponsor
GlaxoSmithKline